Oxylipins and fatty acids may be novel therapeutic targets for cardiovascular disease. The 16 objective was to determine if plasma oxylipins or fatty acids can influence the odds of 17 cardiovascular/cerebrovascular events. In 98 patients (25 female, 73 male) with peripheral artery 18 disease, the prevalence of transient ischemic attacks, cerebrovascular accidents, stable angina 19 and acute coronary syndrome was n= 16, 10, 16, and 24, respectively. Risk factors such as being 20 male, diagnosed hypertension, diabetes mellitus, and hyperlipidemia were not associated with 21 events. Plasma fatty acids and oxylipins were analyzed with gas chromatography and HPLC-22 MS/MS, respectively. None of 24 fatty acids quantified were associated with events. In contrast, 23 39 plasma oxylipins were quantified and 8 were significantly associated with events. These 8 24 oxylipins are known regulators of vascular tone. For example, every 1 unit increase in 25
technology, many novel oxylipins within the octadecanoid and docosanoid subclasses have now 51 also been identified (Gabbs et al. 2015) . The substrate of origin and often the enzyme that 52 produces these novel oxylipins are known, but the role for many of these molecules in 53 physiology and disease remains unclear. It is generalized that most omega 6 fatty acid-derived 54 oxylipins are more pro-inflammatory and vasoconstrictive than those produced from omega 3 55 fatty acids (Gabbs et al. 2015) . Changes in vascular tone and inflammation have been implicated 56 in endothelial dysfunction, hypertension, and atherosclerosis. These processes play a 57 fundamental role in the etiology and progression of both cerebrovascular accidents and 58 myocardial infarction (Puddu et al. 2000; Montezano and Touyz 2012; Shearer and Newman 59 2009) . It is plausible, therefore, that plasma oxylipins may act as significant mediators in the 60 progression of these events. 61
A patient population that is at a high risk for cardiovascular and cerebrovascular events 62 are those living with peripheral artery disease (PAD). PAD is defined as chronic arterial 63 occlusion typically from atherosclerosis to the arteries exclusive of intracranial and coronary 64 circulation, ie: typically in the arms and legs (Ouriel 2001) . However, patients with PAD often 65 progress to coronary artery disease or cerebrovascular disease. PAD patients have a high 66 incidence of hypertension and hypertension is a particularly dangerous risk factor for 67 D r a f t 5 5 cardiovascular outcomes (Caligiuri et al. 2016) . Patients with PAD have a 35% lower survival 68 rate and a higher incidence of myocardial infarctions and cerebrovascular accidents than matched 69 patients with coronary artery disease alone (Welton et al. 2008) . For this reason, a patient 70 population living with PAD was chosen for the current investigation. The hypothesis of the 71 current study was novel eicosanoids derived from omega-6 fatty acids will increase the odds of 72 cardiovascular and cerebrovascular events in patients with PAD. In order to assess this 73 hypothesis, the prevalence of stable angina, acute coronary syndrome, transient ischemic attacks 74 and cerebrovacular accidents in patients living with PAD were assessed with regard to their 75 relationship to coventional risk factors, plasma fatty acid and oxylipin concentrations. 76
Material and Methods 77
Baseline data from patients enrolled in the randomized, double-blinded, placebo 78 controlled FlaxPAD trial (#NCT00781950 at clinicaltrials.gov) were included in this analysis 79 The total sample size for the current study was 98 participants (n=25 females and n=73 males). 83
Further details of the patient population and CONSORT flow diagram have been published 84 elsewhere (Rodriguez-Leyva et al. 2013; Caligiuri et al. 2014) . 85
Lididomics 86
Plasma fatty acids were detected and quantified using gas chromatography and indicated 87 as ng/mL. Details of methodology for fatty acid extraction and quantification are as previously 88 described (Caligiuri et al. 2013 ). An expansive lipidomics analysis searching for over 100 89 D r a f t 6 6 mediators were included in this study. Plasma oxylipins were extracted, detected, and quantified 90 as previously described (Caligiuri et al. 2014) . Oxylipins are represented as nM. 91
Cardiovascular Events 92
Accurate coronary syndrome (ACS) was defined by S-T elevation myocardial infarction, 93 non S-T Elevation myocardial infarction, and unstable angina. These were defined according to 94 the Third Universal definition (Thygesen et al. 2012) . ACS was defined by detecting a change of 95 cardiac biomarkers with one biomarker greater than the 99 th percentile upper reference limit in 96 addition to a minimum of one of the following: ischemic symptoms, new ST changes, new left 97 bundle branch block, pathological Q waves, new loss of healthy myocardium, left ventricular 98 wall abnomality, and/or intracoronary thrombus (Thygesen et al. 2012) . Stable angina pectoris 99 was defined as symptoms of chest discomfort without elevated cardiac biomarkers or evidence of 100 other extraneous plausible causes (eg: gastroesophageal reflux) upon exertion (Thygesen et al. 101 2012) . A cerebrovascular accident (CVA) was defined in accordance with the American Heart 102 Association and American Stroke Association guidelines and diagnosed with a computed 103 tomography scan or magnetic resonance imaging (Sacco et al. 2013) . A transient ischemic attack 104 (TIA) was defined as an event without permanent cerebral damage but rather a brief period of 105 focal cerebral impedance of blood flow that resulted in temporary neurological dysfunction 106 (Easton et al. 2009) . 107
Statistical Analysis 108
Statistical analyses were performed using SAS version 9.3 (Cary, NC, USA). Logistic 109 regression with score selection was utilized to determine the three most significantly associated 110 oxylipins or fatty acids with patient events. Univariate and multivariate forward selection logistic 111 D r a f t 7 7 regression were utilized to determine the association of oxylipins and fatty acids to events while 112 controlling for hypertension, diabetes mellitus, hyperlipidemia, age, sex, smoking status and 113 medications. Bootstrap analysis was utilized for distribution estimation. Probability was assessed 114 with the logit (p) equation produced from the logistic regression analyses. The Wilcoxin-Rank 115 Sum test was utilized for 2 group comparisons due to the non-Gaussian distribution with a post-116 hoc Bonferroni correction. All tests were set at a significance level of 0.05. 117
Results

118
Prevalence of Cardiovascular and Cerebrovascular Events 119 Figure 1 illustrates the prevalence of cardiovascular and cerebrovascular events in the 120 study population. ACS affected the population studied here more than any other clinical event 121
(n=24 patients). No patients presented with all 4 events. Four patients presented with 3 of the 4 122 possible events, 17 patients had 2 events, 20 patients presented with 1 event, and 57 patients had 123 no cardiovascular or cerebrovascular event. 124
Plasma Fatty Acid Concentrations by Presence of Event 125
Because polyunsaturated fatty acids are the substrates to the bioactive oxylipins, plasma 126 fatty acid concentrations were compared by presence of event. Twenty-four plasma fatty acids 127 were detected. Twleve of these were polyunsaturated fatty acids. Plasma fatty acid 128 concentrations (ng/mL) did not differ significantly among patients for presence of angina, ACS, 129 TIA or CVA (Online Supplementary Wilcoxin-Rank sum test followed by a Bonferroni correction, four plasma oxylipins were 135 significantly different between the presence of an event or absence (Figure 2 ). For example, 136 plasma 16-hydroxyeicosatetraenoic acid (HETE) was more than 4 times higher in patients that 137 suffered from a CVA versus patients that did not (Figure 2 ). Using the score selection method of 138 logistic regression, the oxylipins most significantly associated with an event were identified 139 (Tables 1-4 ). For example, only 6 keto (6k)-PGF 1α resulted in an odds ratio less than 1 for the 140 prevalence of TIAs, indicating a protective effect (Table 3 ). This contributed to the ratio of 141 TXB 2 /6kPGF 1α significantly increasing the odds of a TIA by 3.8-fold for every 1 unit increase 142 (Table 3) . 143
It was important to take into account the physiological concentrations of the plasma 144 oxylipins, as logistic regression is per 1 nM increase. Therefore, Figure 3 illustrates the 145 probability of an event by plasma oxylipin concentration observed in the current population 146 (p<0.05). 16-HETE resulted in the greatest increase in the probability of angina and 147 cerebrovascular accidents based on the observed physiological concentration range (Figure 3) . 148
However, 8,9-DiHETrE had the largest slope at 4.53 (as indicated by b in the y = a + bx 149 equation) for prediction of ACS prevalence. 150
Plasma oxylipin profiles were also compared between those with multiple events and 151 those with no event. 17. 3)), thromboxane B 2 (OR: 10.5 (9.77, 11.3)) , 152 and 11,12-DiHETrE (OR: 10.1 (9.52, 10.7)), all increased the odds of having had multiple events 153 (ie: 2 or 3 events) versus no events. β-blockers were significantly associated with the prevalence 154 of angina, ACS and TIAs but not CVAs. Age, sex, smoking status, hyperlipidemia, hypertension, 155 D r a f t 9 9 diabetes mellitus, and other medications were not significantly associated with any event. In the 156 presence of these factors, 16-HETE and 8,9-DiHETrE, still significantly influenced the odds of 157 events (Tables 1-4) . 158
The ratio of TXB 2 to 6kPGF 1α has previously held predictive value for cardiovascular 159 disease and therefore was assessed as a predictor of events in this population (Nishimaki and 160 Seki 1999; de Leval et al. 2004) . TXB 2 /6kPGF 1α increased the odds of a TIA with an odds ratio 161 produced from omega 6 fatty acids. In contrast, one omega-6 derived oxylipin, 6kPGF 1α, had a 196 protective odds ratio of 0.066 against transient ischemic attacks. 6kPGF 1α is the stable product of 197 prostacyclin (PGI 2 ), which is an anti-aggregatory, endothelial-derived vasodilator (Chen et al. 198 2002 The exact mechanism for the relationship with cardiovascular events has yet to be determined 217 and represents an intriguing area for future research. Less surprising was the positive 218 relationship of TXB 2 with events because TXB 2 is the stable product of the potent 219 vasoconstrictor thromboxane A 2 . Similarly, thromboxane B 2 is present in significantly higher 220 concentrations in the coronary circulation in patients with angina versus healthy subjects and 221 during times of chest pain versus no pain (Tada et al. 1981) . 11,12-DiHETrE is a product of 222 D r a f t 11,12-epoxyeicosatrienoic acid (EpETrE). When 11,12-EpETrE is converted by soluble epoxide 223 hydrolase to 11,12-DiHETrE, it causes a significant loss of vasodilation (Sudhahar et al. 2010; 224 Falk et al. 2003) . Therefore, higher concentrations of 11,12-DiHETrE have been implicated in 225 vasoconstriction and even hypertension (Caligiuri et al. 2014) . It may be precisely the vascular 226 constricting properties of 11,12-DiHETrE that explain the increased odds of events in the present 227 study. The positive relationship of plasma 18-HEPE to ACS was unexpected. 18-HEPE is a pre-228 cursor to the E-series resolvins which regulate resolution of inflammation and, therefore, are 229 generalized as protective (Oh et al. 2011; Serhan and Petasis 2011) . It is possible that following 230 ACS, plasma 18-HEPE levels increase as a protective adaptive mechanism to reduce 231 inflammation. Future research is required to determine if 18-HEPE can improve cardiac 232 remodelling post-MI. Other oxylipins may not have been associated with cardiovascular 233 outcomes due to a lack of affect in vascular tone regulation, or they may have a very short half-234 life, or they may have concentrations that are too variable in the population of 98 patients. 235
It is also important to note that the largest slopes in the probability analysis shown in 236
Figure 3 belonged to 8,9-DiHETrE and 16-HETE. This indicates that the odds of events changed 237 more significantly with smaller changes in the plasma concentration of these two oxylipins 238 versus other oxylipins. 8,9-DiHETrE and 16-HETE were also significant predictors of ACS and 239
CVAs, respectively, in the multivariate logistic regression as well as the exploratory analysis of 240 patients with only one event. As a result, these two molecules may prove to be particularly 241 powerful targets for therapeutic investigation or risk marker assessment of ACS and CVAs in the 242 future. 243
The relationship of β-blockers to events was significant for angina, ACS, and TIAs. β-244 blockers are a first-line therapy for hypertension and angina, and are often prescribed to prevent 245 D r a f t 13 13 a secondary myocardial infarction (Bradley et al. 2007) . In this patient population, β-blockers 246 were prescribed for anginal symptoms more often than calcium channel blockers, thus explaining 247 the lack of a significant relationship of calcium channel blockers to angina. For these reasons, it 248 likely explains the relationship between this class of medications and events. 249
Limitations 250
It is important to note that limitations exist within this study. First, because oxylipins 251 were elevated in patients following an event, it is diffcult to ascertain if they are a cause or a 252 consequence of the event. Because of their physiological role (ie: vasoconstricting or 253 inflammatory), it is reasonable to propose that either or both roles are valid. Secondly, the length 254 of time from the clinical event to the measurement of the oxylipins in this study was variable and 255 may have influenced the oxylipin concentrations. Third, information regarding the type of CVA 256 or ACS and the diagnostic method to detect the events was not standardized in the medical 257 records used. Lastly, the distribution of sex was skewed toward males. Future trials in a different 258 population of hypertensive patients should aim to recruit a more even sex distribution to obtain 259 data with high power for both sexes. Future prospective studies following a large cohort of at 260 risk patients may resolve these questions by obtaining plasma oxylipin profiles prior to and 261 immediately after an event. 262
Conclusion 263
In conclusion, this research supports a significant relationship for specific plasma 264 oxylipins such as 16-HETE and 8,9-DiHETrE to cardiovascular and cerebrovascular events in ( 
